Heparin-free extracorporeal circulation via combined nitric oxide releasing/generating surfaces

通过组合的一氧化氮释放/生成表面进行无肝素体外循环

基本信息

  • 批准号:
    10184748
  • 负责人:
  • 金额:
    $ 36.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-01 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract The major limiting factors to clinical applications of blood-contacting materials, ranging from small catheters to large extracorporeal circulation (ECC) devices, include platelet activation leading to thrombosis and infection. Thrombus formation can further lead to obstruction of blood vessels, device malfunction, or even life-threatening situations such as embolism. Systemic anticoagulation is required to prevent clotting in the devices; however, one of the resulting major complications of this is bleeding. During the COVID-19 pandemic, extracorporeal membrane oxygenation (ECMO) has received critical attention as a therapy for patients where mechanical ventilation alone is ineffective. Significant challenges remain due to the increased risks of thrombosis in the circuitry that can be further exacerbated by hypercoagulable blood exhibited by COVID-19 patients. Therefore, there is an urgent necessity and opportunity to combine strategies for preventing thrombosis and infection into multifunctional device coatings for enhanced patency and safety. Our work and others have demonstrated that nitric oxide (NO) release from polymers prevent platelets activation and infection. This technology mimics the vascular endothelial cells lining the blood vessels, as well as other cells in our bodies, producing NO locally to prevent clotting and bacterial biofilm and subsequent infections. Recently we discovered that all of the positive effects can be achieved from polymers physically blended with the NO donor molecule S-nitroso-N-acetylpenicillamine (SNAP), which is nontoxic, inexpensive, and easy to synthesize. Active NO release from the NO donor functionalities in the polymer reduces thrombosis and bacterial infection polymer-blood interface; however, the NO-release strategy alone is limited by the finite reservoir of NO donor functionalities within the polymer that limit the duration of the NO availability at the polymer-blood interface. Our recent work has shown the potential of combining active NO-release with catalytic NO-generating mechanism in a single polymer. The goal of this proposal is to develop a polymer comprised of a NO donor covalently bonded to the polymer to provide active NO-release (without leaching) in combination with immobilized selenocystamine moieties to provide long-term NO-generation. This polymer will combine NO-release and NO-generating strategies for the first time, resulting in a new generation of polymers that possess potent broad-spectrum antimicrobial properties and reduce thrombosis by inhibiting platelet adhesion/activation. The new polymers will be applicable to any blood-contacting device; however, this proposal will focus on studying the combined NO-releasing/NO-generating strategy in vitro for antimicrobial properties and in a rabbit extracorporeal circulation model for prevention of thrombosis. Successful completion of this project will allow progression to early clinical trials and development of a new generation of extracorporeal circuits that can reduce complications while improving the success of patient care.
项目摘要/摘要 限制血液接触材料临床应用的主要因素从小导管到 大型体外循环(ECC)设备,包括导致血栓形成和感染的血小板激活。 血栓形成可进一步导致血管阻塞、设备故障,甚至危及生命 例如血栓等情况。需要全身抗凝来防止设备中的凝血;然而, 由此产生的主要并发症之一是出血。新冠肺炎大流行期间,体外循环 膜氧合(ECMO)作为一种治疗机械性疾病的方法受到了高度重视。 仅靠通风是无效的。由于血栓形成的风险增加,仍然存在重大挑战 新冠肺炎患者表现出的高凝血液可进一步加剧电路。因此, 迫切需要和机会将预防血栓形成和感染的战略结合到 多功能设备涂层,可增强透明度和安全性。 我们和其他人的工作表明,从聚合物中释放的一氧化氮(NO)可以阻止血小板的激活 和感染。这种技术模拟血管内皮细胞衬里血管,以及其他 我们体内的细胞,不会在局部产生任何物质,以防止凝血和细菌生物膜以及随后的感染。 最近我们发现,所有的积极作用都可以通过与聚合物物理混合而实现。 无毒、价廉、易得的NO供体分子S-亚硝基-N-乙酰青霉胺 合成。聚合物中NO供体官能团的活性NO释放可减少血栓形成和细菌 感染聚合物-血液界面;然而,NO释放策略本身受到NO的有限储存量的限制 聚合物内的供体官能团,其限制了在聚合物-血液界面的NO可用性的持续时间。 我们最近的工作表明,将主动释放NO和催化产生NO相结合的潜力 在单一聚合物中的机理。这项提议的目标是开发一种由一氧化氮供体组成的聚合物 共价结合到聚合物上,提供活性的NO释放(不溶出),与 固定化的硒半胱胺部分,以提供长期的NO生成。这种聚合物会结合在一起 首次提出了NO释放和NO生成策略,从而产生了新一代聚合物 具有强大的广谱抗菌特性,并通过抑制血栓形成 血小板黏附/激活。新的聚合物将适用于任何血液接触设备;然而, 本提案将重点研究体外联合NO释放/NO生成策略的抗菌剂。 性质和用于预防血栓形成的兔体外循环模型。成功完成 该项目的实施将使早期临床试验和新一代体外技术的发展成为可能。 电路可以减少并发症,同时提高患者护理的成功率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Elizabeth Joy Brisbois其他文献

Elizabeth Joy Brisbois的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Elizabeth Joy Brisbois', 18)}}的其他基金

Prevention of catheter related infections via photoactive nitric oxide delivery device
通过光敏一氧化氮输送装置预防导管相关感染
  • 批准号:
    10753081
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
Heparin-free extracorporeal circulation via combined nitric oxide releasing/generating surfaces
通过组合的一氧化氮释放/生成表面进行无肝素体外循环
  • 批准号:
    10608084
  • 财政年份:
    2021
  • 资助金额:
    $ 36.42万
  • 项目类别:
Heparin-free extracorporeal circulation via combined nitric oxide releasing/generating surfaces
通过组合的一氧化氮释放/生成表面进行无肝素体外循环
  • 批准号:
    10394301
  • 财政年份:
    2021
  • 资助金额:
    $ 36.42万
  • 项目类别:
Bioinspired antifouling and thromboresistant polymers for blood-contacting interfaces
用于血液接触界面的仿生防污和抗血栓聚合物
  • 批准号:
    10292846
  • 财政年份:
    2020
  • 资助金额:
    $ 36.42万
  • 项目类别:
Bioinspired antifouling and thromboresistant polymers for blood-contacting interfaces
用于血液接触界面的仿生防污和抗血栓聚合物
  • 批准号:
    10591536
  • 财政年份:
    2020
  • 资助金额:
    $ 36.42万
  • 项目类别:
Bioinspired antifouling and thromboresistant polymers for blood-contacting interfaces
用于血液接触界面的仿生防污和抗血栓聚合物
  • 批准号:
    10377491
  • 财政年份:
    2020
  • 资助金额:
    $ 36.42万
  • 项目类别:
Thromboresistant/Bactericidal Intravascular Catheters Based on Electrochemical Nitric Oxide Generation
基于电化学一氧化氮生成的抗血栓/杀菌血管内导管
  • 批准号:
    9147476
  • 财政年份:
    2015
  • 资助金额:
    $ 36.42万
  • 项目类别:
Thromboresistant/Bactericidal Intravascular Catheters Based on Electrochemical Nitric Oxide Generation
基于电化学一氧化氮生成的抗血栓/杀菌血管内导管
  • 批准号:
    8981223
  • 财政年份:
    2015
  • 资助金额:
    $ 36.42万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 36.42万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 36.42万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.42万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.42万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 36.42万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 36.42万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.42万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 36.42万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 36.42万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.42万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了